Liraglutide (another GLP-1 receptor agonist) is a formulation Gillette particularly favors and is expected to become generic soon, making it more accessible than semaglutide for patients.
factualpending
Speaker
Dr. Kyle GilletteEvidence Quote
“there's a Lyra glutide which I like a lot that is going to be generic soon”
Source
Complete Guide to Peptides for Fat Loss, Muscle Building & Longevity | Dr. Kyle Gillett MD— Thomas DeLauerCreated: 8/13/2026, 4:51:25 AM
Your notes
Loading notes...